Altogether, these studies position Npas4 and BDNF as outstanding therapeutic targets against AβOs-induced synaptotoxicity and may constitute targets to prevent the development of AD and other neurodegenerative diseases [86,87,88]. The gene discussed is NPAS4; the disease is neurodegenerative disease.